Status:
COMPLETED
Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550
Lead Sponsor:
Pfizer
Conditions:
Arthritis, Rheumatoid
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to follow the health of subjects who have previously been enrolled in studies of CP-690,550 for treatment of their rheumatoid arthritis. Subjects are only eligible for thi...
Detailed Description
At their last visit of a qualifying study, eligible subjects will be given the opportunity to participate in this study.
Eligibility Criteria
Inclusion
- Subjects who have completed all participation in any other Phase 2B or Phase 3 studies of CP-690,550 for rheumatoid arthritis.
Exclusion
- Any subject who refuses consent.
Key Trial Info
Start Date :
April 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
162 Patients enrolled
Trial Details
Trial ID
NCT00414661
Start Date
April 1 2007
End Date
February 1 2012
Last Update
January 1 2013
Active Locations (72)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Gilbert, Arizona, United States, 85234
2
Pfizer Investigational Site
Tucson, Arizona, United States, 85704
3
Pfizer Investigational Site
Palo Alto, California, United States, 94304
4
Pfizer Investigational Site
San Diego, California, United States, 92108